Selective Cytotoxic Effects of Amygdalin on Neuroblastoma Cells: Mechanisms of Apoptosis, Autophagy and Anti-Metastatic Potential
Abstract
Keywords
Supporting Institution
Project Number
Ethical Statement
References
- [1] Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013; 3(10): a014415. https://doi:10.1101/cshperspect.a014415.
- [2] Wang K, Li Y, Wang L. Chaetocin inhibits the progression of neuroblastoma by targeting JAK2/STAT3 signaling pathway in SH-SY5Y cells. Naunyn Schmiedebergs Arch Pharmacol. 2025; 398(4): 4237-46. https://doi: 10.1007/s00210-024-03426-8.
- [3] Otte J, Dyberg C, Pepich A, Johnsen JI. MYCN Function in Neuroblastoma Development. Front Oncol. 2021; 10: 624079. https://doi:10.3389/fonc.2020.624079.
- [4] Çakır N. Neuroblastoma. Turkiye Klinikleri J Int Med Sci. 2005; 1(3): 103-6
- [5] Beierle EA, Ma X, Stewart J, Nyberg C, Trujillo A, Cance WG, Golubovskaya VM. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma. Cell Cycle. 2010; 9(5): 1005-15. https://doi: 10.4161/cc.9.5.10936.
- [6] Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007; 369(9579): 2106–20. https://doi: 10.1016/S0140-6736(07)60983-0.
- [7] Syrigos KN, Rowlinson-Busza G, Epenetos AA. In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody. Int J Cancer. 1998; 78(6): 712-9. https://doi: 10.1002/(sici)1097-0215(19981209)78:6<712::aid-ijc8>3.0.co;2-d.
- [8] Blaheta RA, Nelson K, Haferkamp A, Juengel E. Amygdalin, quackery or cure?. Phytomedicine. 2016; 23(4): 367-376. https://doi:10.1016/j.phymed.2016.02.004.
Details
Primary Language
English
Subjects
Pharmaceutical Toxicology, Clinical Pharmacology and Therapeutics, Basic Pharmacology, Toxicology
Journal Section
Research Article
Authors
Fatma Çifçi
0009-0006-7902-4348
Türkiye
Hande Yüce
0000-0003-2907-2019
Türkiye
Songül Ünüvar
0000-0001-8454-490X
Türkiye
Publication Date
August 3, 2026
Submission Date
May 9, 2025
Acceptance Date
April 24, 2026
Published in Issue
Year 2026 Volume: 30 Number: 4